Products for Research Use Only
RegisterLogin

Letermovir (GMP)

CAT: 0804-HY-15233GSize: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-15233GSize:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Letermovir (GMP) is the GMP grade of Letermovir. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. Letermovir (GMP) is an orally active CMV inhibitor. Letermovir (GMP) targets the CMV terminase complex rather than CMV DNA polymerase and exerts its antiviral activity. Letermovir (GMP) can be used in the study of CMV infection[1].
CAS Number
917389-32-3
Product Name Alternative
AIC246 (GMP) ; MK-8228 (GMP)
UNSPSC
12352005
Target
CMV
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Smiles
FC1=C(N=C(N2CCN(C3=CC=CC(OC)=C3)CC2)N(C4=CC(C(F)(F)F)=CC=C4OC)[C@H]5CC(O)=O)C5=CC=C1
Molecular Formula
C29H28F4N4O4
Molecular Weight
572.55
References & Citations
[1]Lischka P, et al. In vitro and in vivo activities of the novel anticytomegalovirus compound AIC246. Antimicrob Agents Chemother. 2010 Mar;54 (3) :1290-7.|[2]Wildum S, et al. In vitro drug combination studies of Letermovir (AIC246, MK-8228) with approved anti-human cytomegalovirus (HCMV) and anti-HIV compounds in inhibition of HCMV and HIV replication. Antimicrob Agents Chemother. 2015;59 (6) :3140-8.|[3]Marschall M, et al. In vitro evaluation of the activities of the novel anticytomegalovirus compound AIC246 (letermovir) against herpesviruses and other human pathogenic viruses. Antimicrob Agents Chemother. 2012 Feb;56 (2) :1135-7.|[4]Goldner T, et al. The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase. J Virol. 2011 Oct;85 (20) :10884-93.
Shipping Conditions
Room temperature
Scientific Category
GMP Small Molecules
Clinical Information
Phase 4

Related Products

CatalogName
HY-15233-01Letermovir
HY-15233R-01Letermovir (Standard)
HY-10219G-01Rapamycin (GMP)
HY-N0737AG-01Harmine (GMP)
HY-N0083GBetulin (GMP)
HY-15682G-01TTNPB (GMP)
HY-15794GNemorubicin (GMP)
HY-B1505GAcefylline (GMP)
HY-13506G-01M344 (GMP)
HY-107632GGYY4137 (GMP)

Alternative Products

CatalogName
FL104029-01Letermovir
CS-EO-02006Letermovir d8
TMIH-0298-01Letermovir-d8
TRC-L321007-50MGLetermovir-d3
A21248-500Letermovir 500mg
A21248-100Letermovir 100mg
A21248-5Letermovir 5mg
C13738-2mgLetermovir (AIC246)

Popular Products